Tag Archives: Aortic valve implantation

The Best of Main Arena - SOLACI-SOCIME 2022

The Best of the SOLACI-SOCIME 2022 Main Arena: Structural—Selected Topics of TAVR

- 09 / 08 / 2022 - , , ,

The Best of the SOLACI-SOCIME 2022 Main Arena: Structural—Selected Topics of TAVR

- 09 / 08 / 2022 - , , ,

On the last session from day 1 of SOLACI-SOCIME 2022 on structural pathology, Dr. Raj Makkar, an international expert on the subject, talked about transcatheter aortic valve replacement (TAVR) in pure aortic regurgitation (AR), which presents several implantation challenges, such as insufficient anchoring, embolization, residual regurgitation, ring rupture, etc.  As opposed to patients with aortic…

The Best of Main Arena - SOLACI-SOCIME 2022

The Best of the Main Arena at SOLACI-SOCIME 2022: TAVR Complex Anatomy

- 09 / 08 / 2022 - , ,

In the transcatheter aortic valve replacement (TAVR) session we had a presentation by Dr. John P. Vavalle (USA), head of the Structural Heart Disease Program at the University of North Carolina at Chapel Hill.  In his presentation, he showed how far the limits of percutaneous aortic valve implantation can be stretched by briefly showing successful…

Nuevo estudio confirma la durabilidad del TAVI a 5 años

Fluoroscopy vs. Ultrasound Guided Femoral Access in TAVR

- 28 / 10 / 2021 - , , ,

Ideally, we will not puncture the femoral artery blindly if we are planning to use a big caliber releasing device and a percutaneous closure device during TAVR. The risk of a high or low puncture or the presence of a lateral branch compromising the puncture site might become a major vascular and bleeding complication.  There…

Last articles on TAVR

The latest scientific articles on TAVI published on our website

- 05 / 10 / 2021 - , , , ,

01- TAVR and Anticoagulation: Direct Anticoagulant Agents or Vitamin K Inhibitors? In some patients, using an anticoagulant agent is not an option, it is just prescribed. Based on the French TAVR registry, this research compared long-term mortality, bleeding, and ischemic events after valve implantation. A comparison was made between TAVR and direct vs. classic anticoagulant agents—good old proven and reversible vitamin K inhibitors. Read also HERE 02-…

Doble puente mamario para reducir la chance de nuevas revascularizaciones

Surgical Valve Replacement Might Soon Be History

- 26 / 08 / 2020 - , ,

Patients with dysfunctional biological prosthetic valves have better outcomes with TAVR vs. surgical reintervention, beyond surgical risk. This study outcomes might even call into question the age cutoff to consider a mechanical vs. a biological prosthesis at first surgery. This analysis recently published in JACC looked at the outcomes of both possible strategies to treat…

Top